Literature DB >> 22468059

Comparison Between Concurrent Chemoradiation Followed by Surgery vs. Surgery for Locally Advanced Cancer of Esophagus.

Binay Thakur1, Chun Shan Zhang, Yang Guo, Robin Lama.   

Abstract

Surgery is an accepted standard in the treatment of localized stage cancer of esophagus. But the ideal approach for locally advanced lesions still remains unknown. Patients with locally advanced lesions (cT3-4N1M0) on the basis of CT chest were subjected either to primary surgery or to preoperative chemoradiation followed by surgery. Major postoperative complications (mortality, anastomotic leak and recurrent laryngeal nerve palsy) did not differ in either arm (P = not significant). Complete pathological response was achieved in 31.2% cases in multimodality arm. Four year overall survival was 10% for whole group. Median survival was 14 months and 20 months in surgery and multimodality arm, respectively (p = .288). In multimodal arm, there was significant survival difference between complete responders and nonresponders (p = .02). For locally advanced lesions, surgery alone gives poor outcome and preoperative chemoradiation followed by surgery should be considered for complete responders.

Entities:  

Keywords:  Esophageal cancer; Neoadjuvant chemoradiation; Surgery

Year:  2010        PMID: 22468059      PMCID: PMC3077167          DOI: 10.1007/s12262-010-0182-5

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  12 in total

1.  Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs.

Authors:  K Ikeda; K Ishida; N Sato; K Koeda; K Aoki; Y Kimura; T Iwaya; S Ogasawara; S Iijima; R Nakamura; N Uesugi; C Maesawa; K Saito
Journal:  Dis Esophagus       Date:  2001       Impact factor: 3.429

2.  A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.

Authors:  John D Urschel; Hari Vasan
Journal:  Am J Surg       Date:  2003-06       Impact factor: 2.565

3.  Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma.

Authors:  T Noguchi; H Moriyama; S Wada; S Takeno; M Wakisaka; H Mori; Y Uchida
Journal:  Dis Esophagus       Date:  2003       Impact factor: 3.429

4.  Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.

Authors:  Sarah E Greer; Philip P Goodney; John E Sutton; John D Birkmeyer
Journal:  Surgery       Date:  2005-02       Impact factor: 3.982

5.  Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion.

Authors:  Giovanni de Manzoni; Corrado Pedrazzani; Felice Pasini; Marco Bernini; Anna Maria Minicozzi; Simone Giacopuzzi; Antonio Grandinetti; Claudio Cordiano
Journal:  J Surg Oncol       Date:  2007-03-01       Impact factor: 3.454

6.  The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction.

Authors:  S M Dresner; P J Lamb; M K Bennett; N Hayes; S M Griffin
Journal:  Surgery       Date:  2001-01       Impact factor: 3.982

7.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Authors:  Michael Stahl; Martin Stuschke; Nils Lehmann; Hans-Joachim Meyer; Martin K Walz; Siegfried Seeber; Bodo Klump; Wilfried Budach; Reinhard Teichmann; Marcus Schmitt; Gerd Schmitt; Claus Franke; Hansjochen Wilke
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

8.  Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

Authors:  Laurent Bedenne; Pierre Michel; Olivier Bouché; Chantal Milan; Christophe Mariette; Thierry Conroy; Denis Pezet; Bernard Roullet; Jean-François Seitz; Jean-Philippe Herr; Bernard Paillot; Patrick Arveux; Franck Bonnetain; Christine Binquet
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

9.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

Authors:  Val Gebski; Bryan Burmeister; B Mark Smithers; Kerwyn Foo; John Zalcberg; John Simes
Journal:  Lancet Oncol       Date:  2007-03       Impact factor: 41.316

Review 10.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.